Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2022)

Kodiak Sciences' (KOD) quarterly Amortization of Deferred Charges came in at $2.2 million in Q1 2026, up 4.99% YoY from $2.1 million in Q1 2025, and up 13.19% on a QoQ basis from $2.0 million in Q4 2025.

Analysis

Kodiak Sciences (KOD) Amortization of Deferred Charges (2017 - 2022) Analysis & Trends

Kodiak Sciences (KOD) has 9 years of Amortization of Deferred Charges data on file, last reported at $2.2 million in Q1 2026.

  • Quarterly Amortization of Deferred Charges rose 4.99% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (down 0.98% YoY) and the FY2025 annual result came in at $8.0 million, changed 0.05% from the prior year.
  • Amortization of Deferred Charges improved to $2.2 million in Q1 2026, from $2.0 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $2.2 million in Q1 2026 to a low of $1.7 million in Q3 2022.
  • A 5-year average of $1.9 million and a median of $1.9 million in 2025 frame the typical range for Amortization of Deferred Charges.
  • Annual changes were most pronounced in 2022 — Amortization of Deferred Charges retreated 10.34% — and 2023, when it grew 14.57%.
  • Tracing KOD's Amortization of Deferred Charges over 5 years: stood at $1.7 million in 2022, then rose by 10.93% to $1.9 million in 2023, then gained by 6.09% to $2.1 million in 2024, then fell by 4.13% to $2.0 million in 2025, then advanced by 13.19% to $2.2 million in 2026.
  • The last three Amortization of Deferred Charges figures came in at $2.2 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.90 Mn
Dec 31, 2021 1.90 Mn
Sep 30, 2021 1.91 Mn
Jun 30, 2021 1.94 Mn
Mar 31, 2021 1.96 Mn
Dec 31, 2020 1.94 Mn
Sep 30, 2020 1.59 Mn
Jun 30, 2020 101,000.00
Mar 31, 2020 98,000.00
Dec 31, 2019 97,000.00
Sep 30, 2019 94,000.00
Jun 30, 2019 92,000.00
Mar 31, 2019 90,000.00
Dec 31, 2018 187,000.00
Sep 30, 2018 500,000.00
Jun 30, 2018 1.87 Mn
Mar 31, 2018 1.46 Mn
Dec 31, 2017 769,000.00